Table 1.
Respiratory virusb | No. of virus detections |
Sensitivity, % (95% CI) |
P value | |||
---|---|---|---|---|---|---|
Both positive | NW positive, NS negative | NS positive, NW negative | NW | NS with saline spray | ||
RSV | 3 | 0 | 0 | 100 | 100 | |
Flu A | 7 | 0 | 0 | 100 | 100 | |
Flu B | 2 | 0 | 1 | 67 | 100 | |
HMPV | 2 | 0 | 0 | 100 | 100 | |
PIV (types 1–4) | 6 | 0 | 1 | 86 | 100 | |
HCoV (4 types) | 13 | 1 | 4 | 78 | 94 | |
HRV | 39 | 2 | 4 | 91 | 96 | |
AdV | 1 | 1 | 1 | 67 | 67 | |
HBoV | 0 | 0 | 0 | |||
Totalc | 73 | 4 | 11 | 88 (79–93) | 95 (88–98) | 0.06 |
Shown are results from 121 immunocompetent subjects during 146 incident upper respiratory infections.
RSV, respiratory syncytial virus; Flu, influenza virus; HMPV, human metapneumovirus; PIV, parainfluenza virus; HCoV, human coronaviruses (OC43, 229E, NL63, and HKU1); HRV, human rhinoviruses; AdV, adenovirus; and HBoV, human bocavirus.
A total of 60 swab pairs were negative in both samples; 86 pairs were positive in at least 1 swab, with 2 viruses detected in 2 swab pairs.